Drugs / inactivated vaccine(vero cell) against EV71
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01313715 | Mar → Jun 2011 | hand, foot and mouth disease | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT01508247 | Jan 2012 → Mar 2013 | hand, foot and mouth disease, herpangina | Jiangsu Province Centers for Disease Control and Prevention | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | inactivated vaccine(vero cell) against EV71 | “Recently, an inactivated vaccine(vero cell) against EV71 has been licensed by SFDA in China” NCT01313715 ↗ |
| Known as | Vigoo enterovirus 71 (EV71) vaccine | “This study evaluated the 2-year efficacy, immunogenicity, and safety of the Vigoo enterovirus 71 (EV71) vaccine.” PMID 28077584 ↗ Oct 2016 |
| Modality | Vaccine | “Recently, an inactivated vaccine(vero cell) against EV71 has been licensed by SFDA in China” NCT01313715 ↗ |